- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Clovis Oncology Inc+ Add to Watchlist
CLVS:US46.0100 USD 1.9700 4.47%
As of 20:10:00 ET on 09/17/2014.
Company Profile for Clovis Oncology Inc (CLVS)
Clovis Oncology Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. Clovis target its development programs for the treatment of specific subsets of cancer populations.
Clovis Oncology Inc
Key Executives for Clovis Oncology Inc (CLVS)
|Patrick J MahaffyPresident/CEO/Co-Founder||Erle T MastExec VP/CFO/Secy/Co-Founder|
|Gillian C Ivers-ReadExec VP/Chief Regulatory Ofcr||Andrew R AllenExec VP/Chief Medical Ofcr|
|Steven L HoerterSenior VP:Commercial|